European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

ORION Pharma GmbH, Hamburg, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

ORION Pharma GmbH

Register

Ut
District Court of Hamburg HRB 34720
Lei
3912001IQTZTSDCSNP21

Address

Jürgen-Töpfer-Str. 46, 22763 Hamburg, Germany

Corporate purpose

The trade and distribution of chemical raw materials and pharmaceuticals of any kind. The Company may also engage in all transactions that are suitable for its purpose, with the exception of transactions subject to authorization. The Company is entitled to participate in other companies, in particular to take over their management and representation.

Financials

Employees

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Publications

3 Jun 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
24 Apr 2024
Managing Director: René Lindell · No longer Managing Director: Jari Karlson
15 May 2023
Managing Director: Hao Pan · No longer Managing Director: Satu Ahomäki
28 Feb 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
4 Mar 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
23 Feb 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
1 Oct 2020
Managing Director: Robert B. Borgdorf
10 Mar 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
18 Nov 2019
Address
23 Aug 2019
Wordmark: “CycloPolar“
23 Aug 2019
Wordmark: “GynPolar“
1 Aug 2019
Word figurative mark
8 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
1 Jun 2018
Word figurative mark
1 May 2018
Word figurative mark
28 Mar 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
21 Feb 2018
Word figurative mark: “DER PAD MANAGER PAIN AGITATION DELIRIUM“
13 Feb 2018
Managing Director: Robert B. Borgdorf
1 Sept 2017
Word figurative mark: “Erfolgreiches PAD-Management PAIN AGITATION DELIRIUM“
Year 2017 in Dm
10 trademark filings (9 wordmarks, 1 word figurative mark): CalciDronat, DoniCare, ELDOPAR, MethoCare, NEORON, PLEXORON, TopiCare, ValproCare, VenlaCare …
12 Dec 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
Year 2016 in Dm
7 wordmarks: GraniCare, Mydomagon, PramiCare, Rispecare, RivaCare, RopiCare, Tolcare
10 Feb 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
1 Oct 2015
Word figurative mark: “PAD Management“
1 Oct 2015
Word figurative mark: “PAIN AGITATION DELIRIUM Erfolgreiches PAD Management“
Year 2015 in Dm
7 trademark filings (5 wordmarks, 2 word figurative marks): ARTHROMAGON, DOLORION, OSMAGON, OSORION, OSTEOMAGON …
13 Feb 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
17 Jun 2014
Word figurative mark: “SIMDAX levosimendan Rethink Reactivate Revitalise“
17 Jun 2014
Word figurative mark: “SIMDAX levosimendan“
16 Feb 2014
Wordmark: “INOPROTECTOR“
31 Dec 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
28 Sept 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
13 Aug 2012
Officer: Andreas Glissmann · No longer Officer (1)
14 Dec 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
24 Feb 2011
Managing Director: Satu Ahomäki · No longer Managing Director (1) · Address
22 Feb 2011
Original document: “Liste der Gesellschafter“
6 Dec 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
1 Jun 2010
Word figurative mark
Year 2009 in Euipotm
5 wordmarks: BetaCort-Easyhaler, ContiPolar, FemiPolar, GestaPolar, MediPolar
16 Nov 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
29 Sept 2009
Word figurative mark
1 Sept 2009
Wordmark: “Biocin“
12 Dec 2008
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
30 Oct 2007
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
Year 2005 in Dm
9 trademark filings (6 wordmarks, 1 figurative mark, 2 word figurative marks): Duobiocin, IBUMAGON, Longoprednol, OSTEOMAGON, Venoflexil, Vitenur …
7 Jul 2005
Managing Director (1)
21 Jun 2005
Managing Director (1) · No longer Managing Director (1)
15 Sept 2003
No longer Officer (1)
18 Feb 2003
Managing Director: Jari Karlson · No longer Managing Director (1)
21 May 2002
Reg­is­tra­tion · Managing Director (1) · Officer (1) · Capital: €260,000 · Seat: Hamburg, Germany · Legal form: GmbH · Name: ORION Pharma GmbH · Corporate Purpose

Mentions

9 Aug 2023
Direct parent: Orion Oyj
9 Aug 2023
Ultimate parent: Orion Oyj

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "ORION Pharma GmbH, Hamburg, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close